Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations

NCT: NCT07562477 · NOT_YET_RECRUITING

NCT IDNCT07562477
StatusNOT_YET_RECRUITING
Start Date2026-05-10
Completion2028-06-30

Brief Summary

This study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The study participants are adult patients with hypertension who have been long-term residents (for \>6 months) in high-altitude regions (≥2500 m). They are randomly assigned to one of two groups: a conventional medication group and a remote ischemic conditioning (RIC) intervention group. The study aims to evaluate the effectiveness of a standardized 30-day RIC intervention, as an add-on to conventional antihypertensive medication, for reducing blood pressure in hypertensive immigrants living at high altitude.

Frequently Asked Questions

What is Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations?

Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations is a clinical trial registered under NCT07562477. Current status: NOT_YET_RECRUITING.

What is the status of NCT07562477?

The current status of NCT07562477 (Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations) is: NOT_YET_RECRUITING.

When did Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations start?

Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations started on 2026-05-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.